Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
Durvalumab injection is used to treat non-small cell lung cancer (NSCLC) that has not spread and cannot be removed by surgery. It is given to patients who have received other cancer medicines (eg, platinum) and radiation treatment for their NSCLC. This medicine is also used in combination with etoposide and either carboplatin or cisplatin as first-line treatment for extensive-stage small cell lung cancer (ES-SCLC).
This medicine is to be given only by or under the supervision of your doctor.
This product is available in the following dosage forms: